期刊文献+

鲍曼不动杆菌β内酰胺酶基因表达和对抗生素的耐药性研究 被引量:1

Study on the drug resistance and gene-expression of β-lactamases in Acinetobacter baumanii
下载PDF
导出
摘要 目的:调查淮南地区临床分离的鲍曼不动杆菌耐药性及β内酰胺酶基因型。方法:采用K-B法测定临床分离的32株鲍曼不动杆菌对14种抗菌药物的敏感性,采用聚合酶链反应(PCR)及序列分析的方法分析β内酰胺酶基因型。结果:鲍曼不动杆菌对亚胺培南(100%)、头孢吡肟(87.5%)、阿米卡星(87.5%)和舒普深(84.4%)敏感,对其他抗菌药物的耐药率均较高。β内酰胺酶基因型分布TEM-1阳性率100%(32/32),SHV-12阳性40%(12/32),OXA-2阳性12.5%(4/32),CTX-M各型均阴性,VEB和PER均阴性。结论:淮南地区临床分离的鲍曼不动杆菌耐药严重,至少存在3种不同类型的β内酰胺酶,基因型分别为TEM-1、SHV-12、OXA-2。 Objective:To investigate the resistance and gene-expression of β-lactamases in Acinetobacter baumanii isolated from huai-nan area.Methods:K-B tests were performed to detect the susceptibility of 14 kinds of antimicrobial agents against 32 strains of Acinetobacter baumanii gene-expression of β-lactamases was analyzed by PCR and verificated by DNA sequencing.Results:The highly sensitive rates of 32 strains to Imipenam, Cefepime, Amikaxin and Sulperazon were 100%, 87.5%,87.5% and 84.4%, respectively. The others have highly resistance rates.β-lactamases genotype were positive distributed, the positive rate of TEM-1, SHV-12, OXA-2 was 100%(32/32),40%(12/32),12.5%(4/32) respectively.The other strains (CTX-M,VEB and PER) were negative.Conclusion:The resistance of Acinetobacter baumanii isolated from Huai-nan area was a serious issue and at least 3 kinds of β-lactamases exsisted including TEM-1,SHV-12 and OXA-2.
出处 《中国卫生检验杂志》 CAS 2005年第7期792-792,816,共2页 Chinese Journal of Health Laboratory Technology
关键词 不动杆菌属 Β内酰胺酶类 基因表达 耐药性 Acinetobacter Beta-lactamases Gene-expression Drug resistance
  • 相关文献

参考文献3

二级参考文献13

  • 1Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 2Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 3Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 4Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 5National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 6Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 7吴伟元,陈民钧,王辉.阴沟肠杆菌去阻遏持续高产AmpC酶和超广谱β-内酰胺酶(ESBLs)的检测[J].中国临床药理学杂志,2001,17(2):104-109. 被引量:201
  • 8俞云松,陈亚岗,周伟琳,马亦林.一种新基因型SHV-28 β-内酰胺酶的发现及其特性的初步研究[J].中华检验医学杂志,2001,24(4):204-206. 被引量:37
  • 9朱戌冬,徐英春,吴伟元,王辉,陈民钧.一种新CTX-M型超广谱β-内酰胺酶及其临床意义[J].中华检验医学杂志,2001,24(4):207-210. 被引量:47
  • 10王辉,吴伟元,陈民钧.肠杆菌科细菌中超广谱β-内酰胺酶(ESBL)的研究[J].中华微生物学和免疫学杂志,2001,21(6):676-679. 被引量:100

共引文献654

同被引文献4

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部